Jan. 7 at 1:11 PM
$THMO Thmo is still alive but no news’
On December 31, 2024, the Board of Directors of ThermoGenesis Holdings, Inc. (the “Company”) reached consensus to close the Company’s Indian subsidiary, TotipotentRx Cell Therapy Private Limited (the “Indian Sub”). The closure of the Indian Sub will be effective immediately. Currently, there are minimal activities in the Indian Sub and the closure will not impact the Company’s key business operation.
The unanimous board of director approval is attached as Exhibit 10.1 hereto and incorporated herein by reference.